Japt.gr

Hellenic Atherosclerosis Society
  • HOME
  • ABOUT
    • SCOPE
    • EDITORIAL BOARD
  • CURRENT ISSUE
  • ARCHIVES
    • VOLUME 11 (2020)
      • Volume 11 – Issue 1
      • Volume 11 – Issue 2
      • Volume 11 – Issue 3
      • Volume 11 – Suppl. 1
    • VOLUME 10 (2019)
      • Volume 10 – Issue 1
      • Volume 10 – Suppl. 1
    • VOLUME 9 (2018)
      • Volume 9 – Issue 1
      • Volume 9 – Issue 2
      • Volume 9 – Issue 3
      • Volume 9 – Issue 4
    • VOLUME 8 (2017)
      • Volume 8 – Issue 1
      • Volume 8 – Issue 2
      • Volume 8 – Issue 3
      • Volume 8 – Issue 4
    • VOLUME 7 (2016)
      • Volume 7 – Issue 1
      • Volume 7 – Issue 2
      • Volume 7 – Issue 3
      • Volume 7 – Issue 4
    • VOLUME 6 (2015)
      • Volume 6 – Issue 1
      • Volume 6 – Issue 2
      • Volume 6 – Issue 3
      • Volume 6 – Issue 4
    • VOLUME 5 (2014)
      • Volume 5 – Issue 1
      • Volume 5 – Issue 2
      • Volume 5 – Issue 3
    • VOLUME 4 (2013)
      • Volume 4 – Issue 1
      • Volume 4 – Issue 2
      • Volume 4 – Issue 3
    • VOLUME 3 (2012)
      • Volume 3 – Issue 3
  • FOR AUTHORS
  • SUBMIT MANUSCRIPT
  • CONTACT
  • Menu

Tag Archives: side effects

The effects of atorvastatin 30 mg compared with atorvastatin 40 mg in patients with primary hyperlipidemia: a multicenter study

Christos Rizos, Evangelos Liberopoulos, Eleni Mpilianou, Vasileios Kotsis, Nikolaos Tentolouris, Christina Antza, Ioanna Eleftheriadou, Vasileios Tsimihodimos, Moses Elisaf

CURRENT ISSUE

Parental health status and children’s eating behaviors: An epidemiological study in 1728 Greek 10-12 years old students

How much do we trust randomised clinical trials, and related guidelines for disease management? A critical appraisal

Do platelet mediators and coagulation factors affect the formation of neutrophil extracellular traps?

COVID-19 outbreak: The heart in the center?

Keywords

acute coronary syndrome (4) arterial stiffness (5) Atherosclerosis (19) blood pressure (3) cardiovascular disease (20) cardiovascular diseases (6) cardiovascular events (3) Cardiovascular risk (3) childhood obesity (3) coffee (2) coronary artery disease (4) coronary heart disease (3) diabetes mellitus (9) diet (3) dyslipidemia (14) ezetimibe (4) Familial hypercholesterolemia (4) Heart failure (5) hypertension (7) inflammation (9) Ischemic stroke (3) lipoproteins (4) longevity (3) Mediterranean diet (6) metabolic syndrome (6) mortality (5) NAFLD (3) non-alcoholic fatty-liver disease (4) obesity (6) omega-3 fatty acids (3) outcome (3) PCSK9 inhibitors (4) physical activity (3) physicians (2) platelets (7) primary prevention (3) pulse wave velocity (3) rosuvastatin (3) smoking (3) statins (12) tea (2) thrombin (3) thrombosis (3) treatment (4) type 2 diabetes mellitus (3)
Journal of Atherosclerosis Prevention and Treatment    ©2021
A SiteOrigin Theme